Abstract
https://ir.wavelifesciences.com/static-files/a3dbbb88-aebf-433d-8cb0-fcade9d43c23
1 clinical trial
2 products
2 drugs
1 indication
1 target
Clinical trial
A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients With Huntington's Disease (SELECT-HD)Status: Recruiting, Estimated PCD: 2024-12-01
Indication
Huntington's diseaseProduct
WVE-003Product
PlaceboDrug
WVE-003Drug
placeboTarget
None